Skip to content
No results
  • About Us
  • Contact Us
  • Disclaimer
  • Event Venues
  • Events and Conferences
  • Home
  • Organizer Dashboard
  • Organizer Dashboard
  • Privacy Policy
  • Submit Organizer Form
  • Submit Organizer Form
  • Submit Venue Form
  • Submit Venue Form
  • Subscribe
  • Terms and Conditions
  • Venue Dashboard
  • Venue Dashboard
  • About Us
  • Contact Us
The Pharma Data

  • News
  • Press Releases
  • Research
  • Business
  • Regulatory
  • Events and Conferences
The Pharma Data
  • News

Yemen Starts Sharing Seasonal Influenza Viruses with WHO Centre in London

  • The Pharma Data
  • October 16, 2024

Influenza Virus Sharing Essential for Pandemic Preparedness: Yemen Achieves Milestone with WHO Collaboration Virus sharing is crucial for global pandemic preparedness, enabling the development of vaccine candidates, monitoring antiviral resistance,…

Read MoreYemen Starts Sharing Seasonal Influenza Viruses with WHO Centre in London
  • News

Elanco’s Parvovirus Antibody Boosts Puppy Survival, Eases Vet Clinic Strain

  • The Pharma Data
  • October 16, 2024

Elanco’s Parvovirus Antibody Treatment Saves Thousands of Puppies in First Year Elanco Animal Health has released the first real-world data showcasing the effectiveness of its Canine Parvovirus Monoclonal Antibody (CPMA),…

Read MoreElanco’s Parvovirus Antibody Boosts Puppy Survival, Eases Vet Clinic Strain
  • Press Releases

Lupin Introduces First Generic Version of Pred Forte® in the U.S.

  • The Pharma Data
  • October 16, 2024

Lupin Launches First Generic Pred Forte® Ophthalmic Suspension in the U.S. Prednisolone Acetate Ophthalmic Suspension Marks First Generic Launch with 180-Day CGT Exclusivity Mumbai, Naples, October 15, 2024: Lupin Limited,…

Read MoreLupin Introduces First Generic Version of Pred Forte® in the U.S.
  • Research

Novotech Earns Prestigious US Great Place to Work® Certification

  • The Pharma Data
  • October 16, 2024

Novotech, a full-service international clinical contract research organization (CRO), is proud to announce its recognition as a U.S. Great Place to Work® certified company. This prestigious certification underscores Novotech’s commitment…

Read MoreNovotech Earns Prestigious US Great Place to Work® Certification
  • Press Releases

bit.bio Secures Major Patent Victory for Revolutionary opti-ox™ Cell Programming Technology

  • The Pharma Data
  • October 16, 2024

bit.bio has successfully defended its European patent for the groundbreaking opti-ox™ technology, which facilitates the precise programming of pluripotent stem cells (PSCs), including induced pluripotent stem cells (iPSCs), into any…

Read Morebit.bio Secures Major Patent Victory for Revolutionary opti-ox™ Cell Programming Technology
  • Press Releases

Marinus Pharmaceuticals Expands Intellectual Property with New Patent for ZTALMY® Titration Methods

  • The Pharma Data
  • October 16, 2024

Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a company focused on developing innovative treatments for seizure disorders, announced the addition of a new patent to its intellectual property portfolio. The United States…

Read MoreMarinus Pharmaceuticals Expands Intellectual Property with New Patent for ZTALMY® Titration Methods
  • News

Anthem Blue Cross and Open Table Launch Initiative to Tackle Youth Substance Use Disorder

  • The Pharma Data
  • October 16, 2024

As part of a three-year, $30 million initiative focused on mental health and well-being, the Anthem Blue Cross and Blue Shield Foundation has launched a new program in Shenandoah County,…

Read MoreAnthem Blue Cross and Open Table Launch Initiative to Tackle Youth Substance Use Disorder
  • Regulatory

UroGen Announces FDA Acceptance of New Drug Application for UGN-102

  • The Pharma Data
  • October 16, 2024

PDUFA Goal Date Set for June 13, 2025: UGN-102 Could Be First FDA-Approved Treatment for LG-IR-NMIBC UroGen Pharma Ltd. (Nasdaq: URGN), a biotechnology company committed to developing innovative solutions for…

Read MoreUroGen Announces FDA Acceptance of New Drug Application for UGN-102
  • News

FDA Approves Novocure’s Optune Lua® for Metastatic Non-Small Cell Lung Cancer Treatment

  • The Pharma Data
  • October 16, 2024

FDA Approves Optune Lua® as First-of-its-Kind Treatment for Metastatic Non-Small Cell Lung Cancer Novocure (NASDAQ: NVCR) announced that the U.S. Food and Drug Administration (FDA) has approved Optune Lua®, a…

Read MoreFDA Approves Novocure’s Optune Lua® for Metastatic Non-Small Cell Lung Cancer Treatment
  • Business

Lenovo Launches First AI Avatar for Alzheimer’s and Dementia Care

  • The Pharma Data
  • October 16, 2024

At Lenovo Tech World, Lenovo™, in collaboration with Innovations in Dementia, launched “Alzheimer’s Intelligence,” a photorealistic 3D avatar powered by AI, designed to support individuals and families affected by dementia…

Read MoreLenovo Launches First AI Avatar for Alzheimer’s and Dementia Care
  • Regulatory

FDA Clears SPECTRALIS Flex Module, Enhancing Advanced Ophthalmic Imaging for Underserved Patients

  • The Pharma Data
  • October 15, 2024

Heidelberg Engineering, a leading provider of ophthalmic imaging and healthcare data solutions, has announced that the FDA has granted clearance for its SPECTRALIS® Flex Module. This advanced, multimodal imaging platform…

Read MoreFDA Clears SPECTRALIS Flex Module, Enhancing Advanced Ophthalmic Imaging for Underserved Patients
  • Regulatory

Bausch + Lomb Gains FDA Approval for enVista Envy Intraocular Lens Offering Full Range of Vision

  • The Pharma Data
  • October 15, 2024

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a global leader in eye health, has announced that the U.S. Food and Drug Administration has approved the enVista® Envy™ intraocular lens (IOL). This…

Read MoreBausch + Lomb Gains FDA Approval for enVista Envy Intraocular Lens Offering Full Range of Vision
PrevNext
UK Biotech Day
Global Clinical Trial Supply Forum 2026 I Frankfurt, Germany
Global Clinical

About

The Pharma Data is an Information-Centric Website focused mainly on the Pharmaceutical Industry Online It is a B2B Platform mainly focused on the latest Pharmaceutical News, Press releases, Industry-related updates, Events, and Conferences. With The Pharma Data, you can get all the information that happening in the Pharmaceutical industry.

Advertise With Us: marketing@thepharmadata.com

Latest Posts

  • Bepirovirsen Gains European Medicines Agency Review as a Potential First-in-Class Therapy for Chronic Hepatitis B
  • Novartis to Acquire Excellergy, Inc., Strengthening Allergy Leadership with Next-Generation Anti-IgE Innovation
  • AbbVie to Present New Data Advancing Care in Immune-Mediated Skin Diseases at AAD 2026
  • About Us
  • Disclaimer
  • Privacy Policy
  • Terms and Conditions
  • Contact Us

Copyright © 2026 | The Pharma Data | Marnet Technologies Pvt Ltd | All Rights Reserved.